Cytobot® 2000 is a CTC detection system completely independently developed by Huixian Pharmaceutical. It adopts the leading "physical + immune" microfluidic double enrichment principle, fully automatic operation, in-situ fluorescent staining, and has the characteristics of accuracy, automation, and efficiency.
Real photos of circulating tumor cells under microscope
Platform advantages
Efficient CTC capture
Using the "physical + immune" double enrichment principle, the capture rate is > 90% and detection results are more accurate.
Rapid detection
The detection cycle is short, the manual operation steps are few, and the results are obtained on the same day.
High degree of automation
Enrichment and dyeing are automatically carried out by the instrument's mechanical arm without any manual labor.
Wider clinical application value
In addition to CTC counting, we can also detect the proteins of PD-L1, HER-2 in CTC cells to guide drug selection.